Balance Sheet
Cash Flow Statement
AmortizationCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MediWound (MDWD) Depreciation & Amortization (CF) (2016 - 2025)

Historic Depreciation & Amortization (CF) for MediWound (MDWD) over the last 13 years, with Q3 2025 value amounting to $418000.0.

  • MediWound's Depreciation & Amortization (CF) rose 21578.95% to $418000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $851000.0, marking a year-over-year increase of 1985.92%. This contributed to the annual value of -$1.5 million for FY2024, which is 21381.43% down from last year.
  • According to the latest figures from Q3 2025, MediWound's Depreciation & Amortization (CF) is $418000.0, which was up 21578.95% from $394000.0 recorded in Q2 2025.
  • MediWound's 5-year Depreciation & Amortization (CF) high stood at $418000.0 for Q3 2025, and its period low was -$361000.0 during Q3 2024.
  • For the 5-year period, MediWound's Depreciation & Amortization (CF) averaged around $135000.0, with its median value being $321000.0 (2021).
  • In the last 5 years, MediWound's Depreciation & Amortization (CF) plummeted by 22321.43% in 2021 and then skyrocketed by 22145.21% in 2024.
  • Quarter analysis of 5 years shows MediWound's Depreciation & Amortization (CF) stood at -$276000.0 in 2021, then skyrocketed by 202.9% to $284000.0 in 2022, then increased by 21.83% to $346000.0 in 2023, then rose by 14.74% to $397000.0 in 2024, then grew by 5.29% to $418000.0 in 2025.
  • Its Depreciation & Amortization (CF) stands at $418000.0 for Q3 2025, versus $394000.0 for Q2 2025 and -$358000.0 for Q1 2025.